Average Insider

Where insiders trade, we follow

Sullivan Christopher Ryan

Chief Financial Officer
CIK: 1810417

All Transactions

DateCompanyTypeSharesPriceValueActions
May 7, 2026Avalo Therapeutics, Inc. (AVTX)S18,606$24.12$448,817.65View Details Filing
May 6, 2026Avalo Therapeutics, Inc. (AVTX)S12,347$19.28$238,093.37View Details Filing
May 6, 2026Avalo Therapeutics, Inc. (AVTX)S2,700$20.76$56,052.00View Details Filing
May 6, 2026Avalo Therapeutics, Inc. (AVTX)S8,900$22.57$200,913.05View Details Filing
May 6, 2026Avalo Therapeutics, Inc. (AVTX)S13,834$18.55$256,655.28View Details Filing
May 6, 2026Avalo Therapeutics, Inc. (AVTX)S9,219$21.37$197,008.19View Details Filing
Apr 30, 2026Avalo Therapeutics, Inc. (AVTX)S8,457$13.23$111,853.13View Details Filing
Apr 29, 2026Avalo Therapeutics, Inc. (AVTX)S8,458$13.09$110,736.36View Details Filing
Apr 2, 2026Avalo Therapeutics, Inc. (AVTX)S6,200$17.02$105,553.14View Details Filing
Apr 2, 2026Avalo Therapeutics, Inc. (AVTX)S1,780$17.57$31,269.97View Details Filing
Apr 1, 2026Avalo Therapeutics, Inc. (AVTX)S7,479$16.83$125,840.91View Details Filing
Apr 1, 2026Avalo Therapeutics, Inc. (AVTX)S500$15.86$7,929.00View Details Filing
Version: v26.5.2